Research ArticleArticle
The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis
Milla Johanna Kviatkovsky, Sofia Ramiro, Robert Landewé, Maxime Dougados, Florence Tubach, Nicholas Bellamy, Marc Hochberg, Philippe Ravaud, Emilio Martin-Mola, Hassane Awada, Claire Bombardier, David Felson, Najia Hajjaj-Hassouni, Isabelle Logeart, Marco Matucci-Cerinic, Mart van de Laar and Désirée van der Heijde
The Journal of Rheumatology June 2016, jrheum.151244; DOI: https://doi.org/10.3899/jrheum.151244
Milla Johanna Kviatkovsky
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Sofia Ramiro
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Robert Landewé
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Maxime Dougados
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Florence Tubach
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Nicholas Bellamy
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Marc Hochberg
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Philippe Ravaud
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Emilio Martin-Mola
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Hassane Awada
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Claire Bombardier
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
David Felson
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Najia Hajjaj-Hassouni
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Isabelle Logeart
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Marco Matucci-Cerinic
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Mart van de Laar
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Désirée van der Heijde
From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy. M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl. Accepted for publication May 17, 2016.
Article Information
jrheum.151244
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online June 15, 2016.
Article Versions
- You are currently viewing a Latest version of this article (June 15, 2016 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2016 The Journal of Rheumatology
Author Information
- Milla Johanna Kviatkovsky,
- Sofia Ramiro,
- Robert Landewé,
- Maxime Dougados,
- Florence Tubach,
- Nicholas Bellamy,
- Marc Hochberg,
- Philippe Ravaud,
- Emilio Martin-Mola,
- Hassane Awada,
- Claire Bombardier,
- David Felson,
- Najia Hajjaj-Hassouni,
- Isabelle Logeart,
- Marco Matucci-Cerinic,
- Mart van de Laar and
- Désirée van der Heijde
- From the Department of Rheumatology, Leiden University Medical Center, Leiden; Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam; Arthritis Center Twente, Medisch Spectrum Twente, University Twente, Enschede, the Netherlands; Department of Rheumatology B, Paris-Descartes University, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, UMR 1123; INSERM, UMR 1123, CIC-EC 1425; APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; INSERM, U738; AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique; Université Paris Descartes; Pfizer SAS, Paris, France; School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital, Brisbane, Australia; Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland; Boston University School of Medicine, Boston, Massachusetts, USA; Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid, Madrid, Spain; Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department, Beirut, Lebanon; Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto; Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network; Institute for Work and Health; Mount Sinai Hospital, Toronto, Ontario, Canada; Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital, Salé, Morocco; Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence, Florence, Italy.
M.J. Kviatkovsky, DO, MPH, Department of Rheumatology, Leiden University Medical Center; S. Ramiro, MD, MSc, PhD, Department of Rheumatology, Leiden University Medical Center; R. Landewé, MD, PhD, Department of Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center; M. Dougados, MD, Department of Rheumatology B, Paris-Descartes University; F. Tubach, MD, Université Paris Diderot, Sorbonne Paris Cité, UMR 1123, and INSERM, UMR 1123, CIC-EC 1425, and APHP, Hôpital Bichat, Département d’Epidémiologie et Recherche Clinique; N. Bellamy, MD, MSc, MBA, School of Medicine, University of Queensland, Royal Brisbane and Women’s Hospital; M. Hochberg, MD, MPH, MACP, Departments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine; P. Ravaud, MD, PhD, INSERM, U738, and AP-HP, Hôpital Hôtel-Dieu, Centre d’Epidémiologie Clinique, and Université Paris Descartes; E. Martin-Mola, MD, Rheumatology Department, Hospital Universitario La Paz, Universidad Autónoma Madrid; H. Awada, MD, Hotel-Dieu de France Hospital, Saint Joseph University, Rheumatology Department; C. Bombardier, MD, Division of Rheumatology, Department of Health Policy, Management, and Evaluation, University of Toronto, and Division of Clinical Decision Making and Health Care, Toronto General Research Institute, University Health Network, and Institute for Work and Health, and Mount Sinai Hospital; D. Felson, MD, PhD, Boston University School of Medicine; N. Hajjaj-Hassouni, MD, Mohammed Vth University, LIRPOS URAC30, Rheumatology and Physical Rehabilitation Department, El Ayachi Hospital; I. Logeart, Pfizer SAS; M. Matucci-Cerinic, MD, PhD, Department of Experimental and Clinical Medicine, Division of Rheumatology AOUC, University of Florence; M. van de Laar, MD, PhD, Arthritis Center Twente, Medisch Spectrum Twente, University Twente; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center.
Address correspondence to Dr. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, P.O. Box 9600, Leiden, the Netherlands. E-mail: mail@dvanderheijde.nl.
Accepted for publication May 17, 2016.
Article usage
Statistics from Altmetric.com
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis
Milla Johanna Kviatkovsky, Sofia Ramiro, Robert Landewé, Maxime Dougados, Florence Tubach, Nicholas Bellamy, Marc Hochberg, Philippe Ravaud, Emilio Martin-Mola, Hassane Awada, Claire Bombardier, David Felson, Najia Hajjaj-Hassouni, Isabelle Logeart, Marco Matucci-Cerinic, Mart van de Laar, Désirée van der Heijde
The Journal of Rheumatology Jun 2016, jrheum.151244; DOI: 10.3899/jrheum.151244
The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis
Milla Johanna Kviatkovsky, Sofia Ramiro, Robert Landewé, Maxime Dougados, Florence Tubach, Nicholas Bellamy, Marc Hochberg, Philippe Ravaud, Emilio Martin-Mola, Hassane Awada, Claire Bombardier, David Felson, Najia Hajjaj-Hassouni, Isabelle Logeart, Marco Matucci-Cerinic, Mart van de Laar, Désirée van der Heijde
The Journal of Rheumatology Jun 2016, jrheum.151244; DOI: 10.3899/jrheum.151244